David Donabedian
David Donabedian is a seasoned CEO and executive with over 20 years of experience in business development, venture teams, and company creation. He has a proven track record of leading and launching early-stage organizations in the biotech and biopharma industries. David is a co-founder and CEO of precision medicine companies Solu Therapeutics, DEM Bio, Axial Therapeutics, and ImmuneID. He is also ...
N/A
Technology
N/A
Founded
N/A
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
David Donabedian
Industry
N/A
Technology
N/A
Location
United States of America
Founded
N/A
Employees
N/A
Category
Investor
Contact Information
Email
dd@longwoodfund.com
Phone
N/A
Address
N/A